Neonatal Steroids Affect Preterm Infant Body Composition

Why It Matters

Understanding steroid‑induced shifts in fat and muscle informs clinicians about future metabolic and developmental risks, guiding safer neonatal care protocols.

Key Takeaways

• Steroid exposure raises fat mass, lowers lean mass at discharge
• DXA provides precise body‑composition data for preterm infants
• Hormonal changes (IGF‑1, leptin) accompany altered tissue growth
• Tailored dosing and nutrition may mitigate long‑term metabolic risks

Pulse Analysis

Neonatal corticosteroids have long been a cornerstone in preventing bronchopulmonary dysplasia and other complications of extreme prematurity. While lifesaving, their systemic effects extend beyond the lungs, influencing the delicate balance of adipose, muscle, and bone tissue in the smallest patients. The recent correction by Kraemer and colleagues sharpens earlier findings by applying rigorous dual‑energy X‑ray absorptiometry (DXA) protocols, revealing that infants who receive steroids tend to leave the NICU with a higher proportion of fat relative to lean mass. This shift is not merely cosmetic; early adiposity has been linked to insulin resistance, hypertension, and cardiovascular disease later in life, underscoring the importance of precise growth monitoring.

The study also delves into the endocrine milieu accompanying these compositional changes. Elevated leptin and reduced IGF‑1 levels were observed, reflecting steroid‑driven alterations in energy balance and tissue growth pathways. Such hormonal signatures provide a mechanistic bridge between immediate body‑composition outcomes and the potential for metabolic programming that persists into childhood and adulthood. By quantifying these biomarkers alongside DXA data, clinicians gain a more comprehensive picture of how early pharmacologic interventions shape long‑term health trajectories.

Clinically, the implications are twofold. First, neonatal teams may need to recalibrate steroid dosing schedules, favoring the lowest effective exposure to mitigate adverse growth effects. Second, nutrition protocols in NICUs should be synchronized with steroid therapy, emphasizing protein‑rich feeds and micronutrient support to counteract lean‑mass loss. Ongoing longitudinal studies will be essential to confirm whether these early adjustments translate into reduced rates of metabolic syndrome among former preterm infants, ultimately informing evidence‑based guidelines that balance immediate respiratory benefits with lifelong health considerations.